CLINDAMYCIN-M

Capsules, 0.15 g
Clindamycin

CLINDAMYCIN-M is an antibiotic belonging to the lincosamide group. It has a broad spectrum of antibacterial activity and acts as a bacteriostatic agent. It is active against many pathogens causing infectious diseases, including Streptococcus pneumoniae, a causative agent of pneumonia.

Due to its high antibacterial activity, CLINDAMYCIN-M may be used for the treatment of various infectious and inflammatory diseases caused by microorganisms susceptible to clindamycin.

Composition:

Active substance: clindamycin. 1 capsule contains clindamycin hydrochloride equivalent to 0.15 g (150 mg) of clindamycin.
Excipients: calcium stearate, lactose monohydrate, colloidal anhydrous silicon dioxide, sodium methylparaben (E219), sodium propylparaben (E217), gelatin, titanium dioxide (E171), tartrazine (E102), erythrosine (E127), brilliant blue, amaranth (E123).

Dosage form:

Capsules.

Main physicochemical properties:

Hard gelatin capsules with a pink cap and pink body; the capsule contents are a white powder.

Pharmacotherapeutic group:

Antibacterial agents for systemic use. Lincosamides. Clindamycin.
ATC code: J01FF01.

Shelf life:

2 years.

Storage conditions:

Store in the original package at a temperature not exceeding 25°C. Keep out of the reach of children.

Incompatibility:

Because of the antagonism between clindamycin and erythromycin, their concomitant use is not recommended. Do not administer concomitantly with ampicillin, diphenylhydantoin, barbiturates, aminophylline, calcium gluconate, or magnesium sulfate.

Package:

10 capsules in a blister.
1 blister per carton.

Prescription status:

Prescription only.

Manufacturer:

PJSC Monfarm

Manufacturer’s location and address of the manufacturing site:

8 Zavodska St., Monastyryshche, Cherkasy Region, 19100, Ukraine.

For detailed information, please refer to the Instructions for Medical Use.

Information on this medicinal product is intended exclusively for healthcare professionals.